Technical Brief - SimpliFiH Solutions

Reduce phase I timelines by at least 3 months vs traditional approaches

Like Comment

SimpliFiH™ Solutions is specifically designed to reduce phase I timelines by at least 3 months vs traditional approaches. This service is also designed for the flexibility required to fit your molecule and drug program:

  1. API to OEL 4 – dedicated kilo-labs and teams in place to provide the quantities necessary for preclinical and early clinical trials
  2. Solid state characterization – API physicochemical characterization, aqueous solubility, salt and polymorph screening services
  3. Solubility and solubility rate enhancement – proprietary modeling / technology selection services and manufacture of enabled phase I drug product with required dissolution rate and/or aqueous solubility
  4. Drug product in phase-appropriate format: powder-in-capsule (PIC), powder-in-bottle (PIB), liquid-filled hard capsules (LFHC) or tablets

To learn more about SimpliFiH™, please download our technical brief (PDF).

Don`t forget to register for our upcoming webinars:

Lonza Pharma & Biotech

At Lonza Pharma & Biotech we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome, at the time when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of biological and chemical drugs. We continuously invest to solve not just the current, but also the future challenges. Together, we can bring your next medicine to life.
5 Contributions
0 Following